<VariationArchive VariationID="2945373" VariationName="NM_005045.4(RELN):c.9474dup (p.Cys3159fs)" VariationType="Duplication" Accession="VCV002945373" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3105144" VariationID="2945373">
      <GeneList>
        <Gene Symbol="LOC126860130" FullName="BRD4-independent group 4 enhancer GRCh37_chr7:103130126-103131325" GeneID="126860130" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="103489679" stop="103490878" display_start="103489679" display_stop="103490878" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="RELN" FullName="reelin" GeneID="5649" HGNC_ID="HGNC:9957" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="103471789" stop="103989658" display_start="103471789" display_stop="103989658" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="103112230" stop="103629962" display_start="103112230" display_stop="103629962" Strand="-" />
          </Location>
          <OMIM>600514</OMIM>
          <Haploinsufficiency last_evaluated="2023-12-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RELN">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-12-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RELN">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SLC26A5-AS1" FullName="SLC26A5 antisense RNA 1" GeneID="101927870" HGNC_ID="HGNC:55680" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="103445207" stop="103514007" display_start="103445207" display_stop="103514007" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_005045.4(RELN):c.9474dup (p.Cys3159fs)</Name>
      <CanonicalSPDI>NC_000007.14:103490798:C:CC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="103490798" stop="103490799" display_start="103490798" display_stop="103490799" variantLength="1" positionVCF="103490798" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="103131245" stop="103131246" display_start="103131245" display_stop="103131246" variantLength="1" positionVCF="103131245" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
      </Location>
      <ProteinChange>C3159fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.103131246dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.103131246dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.103490799dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.103490799dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011877.2" sequenceAccession="NG_011877" sequenceVersion="2" change="g.503718dup">
            <Expression>NG_011877.2:g.503718dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_084631.1" sequenceAccession="NG_084631" sequenceVersion="1" change="g.1221dup">
            <Expression>NG_084631.1:g.1221dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005045.4" sequenceAccession="NM_005045" sequenceVersion="4" change="c.9474dup" MANESelect="true">
            <Expression>NM_005045.4:c.9474dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005036.2" sequenceAccession="NP_005036" sequenceVersion="2" change="p.Cys3159fs">
            <Expression>NP_005036.2:p.Cys3159fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_173054.3" sequenceAccession="NM_173054" sequenceVersion="3" change="c.9474dup">
            <Expression>NM_173054.3:c.9474dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_774959.1" sequenceAccession="NP_774959" sequenceVersion="1" change="p.Cys3159fs">
            <Expression>NP_774959.1:p.Cys3159fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005045.4(RELN):c.9474dup (p.Cys3159fs) AND multiple conditions" Accession="RCV003801027" Version="1">
        <ClassifiedConditionList TraitSetID="35358">
          <ClassifiedCondition DB="MedGen" ID="C4225327">Familial temporal lobe epilepsy 7</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0796089">Norman-Roberts syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10973257</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26046367</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28454995</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="35358" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2697" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lissencephaly 2</ElementValue>
                <XRef ID="Lissencephaly+2/4270" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lissencephaly syndrome Norman-Roberts type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lissencephaly 2 (Norman-Roberts type)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Norman-Roberts syndrome</ElementValue>
                <XRef ID="MONDO:0009760" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LIS2</ElementValue>
                <XRef Type="MIM" ID="257320" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3277" />
                <XRef ID="3277" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16780" />
                <XRef ID="16780" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="89844" DB="Orphanet" />
              <XRef ID="C0796089" DB="MedGen" />
              <XRef ID="MONDO:0009760" DB="MONDO" />
              <XRef Type="MIM" ID="257320" DB="OMIM" />
            </Trait>
            <Trait ID="33546" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial temporal lobe epilepsy 7</ElementValue>
                <XRef ID="MONDO:0014639" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ETL7</ElementValue>
                <XRef Type="MIM" ID="616436" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal dominant epilepsy with auditory features (ADEAF) is a focal epilepsy syndrome with auditory symptoms and/or receptive aphasia as prominent ictal manifestations. The most common auditory symptoms are simple unformed sounds including humming, buzzing, or ringing; less common forms are distortions (e.g., volume changes) or complex sounds (e.g., specific songs or voices). Ictal receptive aphasia consists of a sudden onset of inability to understand language in the absence of general confusion. Less commonly, other ictal symptoms may occur, including sensory symptoms (visual, olfactory, vertiginous, or cephalic) or motor, psychic, and autonomic symptoms. Most affected individuals have focal to bilateral tonic-clonic seizures, usually accompanied by "focal aware" and "focal impaired-awareness" seizures, with auditory symptoms as a major focal aware seizure manifestation. Some persons have seizures precipitated by sounds such as a ringing telephone. Age at onset is usually in adolescence or early adulthood (range: age 4-50 years). The clinical course of ADEAF is benign. Seizures are usually well controlled after initiation of medical therapy.</Attribute>
                <XRef ID="NBK1537" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16112" />
                <XRef ID="16112" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301709</ID>
                <ID Source="BookShelf">NBK1537</ID>
              </Citation>
              <XRef ID="101046" DB="Orphanet" />
              <XRef ID="C4225327" DB="MedGen" />
              <XRef ID="MONDO:0014639" DB="MONDO" />
              <XRef Type="MIM" ID="616436" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8548557" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="18791727|MedGen:C4225327;C0796089" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004589921" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10973257</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26046367</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28454995</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with RELN-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Cys3159Valfs*7) in the RELN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RELN are known to be pathogenic (PMID: 10973257, 26046367, 28454995).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RELN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.103131245_103131246insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225327" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0796089" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8548557" TraitType="Disease" MappingType="XRef" MappingValue="C4225327" MappingRef="MedGen">
        <MedGen CUI="C4225327" Name="Familial temporal lobe epilepsy 7" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8548557" TraitType="Disease" MappingType="XRef" MappingValue="C0796089" MappingRef="MedGen">
        <MedGen CUI="C0796089" Name="Norman-Roberts syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

